T3 Beta-AT Injection
Marketer
Spranza Vita Pharmaceutical LLP
Salt Composition
Artesunate (120mg)
Overview T3 Beta-AT Injection
Beta-AT Injection T3 is an anti-malarial drug, indicated for treating malaria infections. It's unsuitable for malaria prevention or severe malaria cases involving neurological, pulmonary, or renal compromise. Administration is strictly by injection from a healthcare provider; self-injection is prohibited. This injectable route is reserved for instances where oral medication is infeasible. Potential side effects include headache, lightheadedness, fatigue, and anorexia. Injection site reactions such as pain, inflammation, or erythema may also occur. Prolonged side effects warrant medical consultation. Post-treatment, weekly blood tests to monitor parasite presence may be conducted over a four-week period.
Primary Ingredients of T3 Beta-AT Injection
No text was provided. Please provide the text you wish me to rephrase.
Uses of T3 Beta-AT Injection
Plasmodium infection
Major Benefits of T3 Beta-AT Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of T3 Beta-AT Injection:
- Headache
- Dizziness
- Weakness
- Loss of appetite
- Injection site reactions (pain, swelling, redness)
How to use T3 Beta-AT Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How T3 Beta-AT Injection works:
T3 Beta-AT Injection is an antiparasitic drug that eliminates malarial parasites by generating intracellular free radicals, leading to parasite death.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside T3 Beta-AT Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Employing T3 Beta-AT Injection during pregnancy may present risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescription. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
Administration of T3 Beta-AT Injection while breastfeeding appears to pose minimal risk. Available human data indicate negligible infant hazard associated with the medication.
DrivingUNSAFE
Administering T3 Beta-AT Injection can induce drowsiness, visual disturbances, and dizziness, potentially impairing alertness. Driving should be avoided if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of T3 Beta-AT Injection to individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of T3 Beta-AT Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take T3 Beta-AT Injection :
Should you forget a scheduled T3 Beta-AT Injection, seek your physician's advice.
Facts to Know About T3 Beta-AT Injection
| Label | Value |
|---|---|
| Chemical Classification | Sesquiterpene lactones |
| Developing Habits | No. |
| Type of Treatment | Antimalarial Drugs |
| Action Category | Artemisinin-based antimalarials |
3,018 People bought this recently